Thompson LD (2014) Chronic lymphocytic thyroiditis (Hashimoto thyroiditis). Ear Nose Throat J 93: 152-153.
LiVolsi VA, Baloch ZW (2018) The Pathology of Hyperthyroidism. Front Endocrinol (Lausanne) 9: 737. https://doi.org/10.3389/fendo.2018.00737.
Sande CM, Tondi R, I, LiVolsi VA (2023) The Thyroid Pathologist Meets Therapeutic Pharmacology. Endocr Pathol 1–9. https://doi.org/10.1007/s12022-023-09749-1.
Ghossein RA, Rosai J, Heffess C (1997) Dyshormonogenetic Goiter: A Clinicopathologic Study of 56 Cases. Endocr Pathol 8: 283–292. EP0804283. https://doi.org/10.1007/BF02739930
Camargo RY, Gross JL, Silveiro SP, Knobel M, Medeiros-Neto G (1998) Pathological Findings in Dyshormonogenetic Goiter with Defective Iodide Transport. Endocr Pathol 9: 225–233. EP0903225. https://doi.org/10.1007/BF02739962
Fadda G, Baloch Z, LiVolsi VA (1999) Dyshormonogenetic goiter. Int J Surg Pathol 125–131.
Braham E, Ben RH, Marghli A, Kilani T, El MF (2013) A rare and particular form of goiter to recognize. Ann Transl Med 1:21. atm-01–02–21. https://doi.org/10.3978/j.issn.2305-5839.2013.01.10
Lee KW, Shin Y, Lee S, Lee S (2021) Inherited Disorders of Thyroid Hormone Metabolism Defect Caused by the Dysregulation of Selenoprotein Expression. Front Endocrinol (Lausanne) 12:803024. https://doi.org/10.3389/fendo.2021.803024
Wolfe HJ, Melvin KEW, Cervi-Skinner SJ (1973) C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med 289: 437-441.
Article CAS PubMed Google Scholar
Albores-Saavedra J, LiVolsi VA, Williams ED (1985) Medullary carcinoma. Semin Diagn Pathol 2: 137-146.
Perry A, Molberg K, Albores-Saavedra J (1996) Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities. Cancer 77: 750-756. https://pubmed.ncbi.nlm.nih.gov/8616768/ [pii] https://doi.org/10.1002/(sici)1097-0142(19960215)77:4<750::aid-cncr22>3.0.co;2-z
Article CAS PubMed Google Scholar
LiVolsi VA (1997) C cell hyperplasia/neoplasia. J Clin Endocrinol Metab 82: 39-41.
Article CAS PubMed Google Scholar
Guyetant S, Josselin N, Savagner F, Rohmer V, Michalak S, Saint-Andre JP (2003) C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients. Mod Pathol 16: 756-763. https://doi.org/10.1097/01.MP.0000081727.75778.0C.
Verga U, Ferrero S, Vicentini L, Brambilla T, Cirello V, Muzza M, Beck-Peccoz P, Fugazzola L (2007) Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia? Endocr Relat Cancer 14:393–403. 14/2/393. https://doi.org/10.1677/ERC-06-0053
Fuchs TL, Bell SE, Chou A, Gill AJ (2019) Revisiting the Significance of Prominent C Cells in the Thyroid. Endocr Pathol 30: 113-117. https://pubmed.ncbi.nlm.nih.gov/30694510/ [pii]; https://doi.org/10.1007/s12022-019-9567-6
La Rosa S, Rindi G, Solcia E, Tang LH (2019) Gastric neuroendocrine neoplasms. In: WHO Classification of Digestive System Tumours. Lyon: ARC. pp. 104–109.
La Rosa S, Solcia E (2020) New insights into the classification of gastric neuroendocrine tumours, expanding the spectrum of ECL-cell tumours related to hypergastrinaemia. Histopathology 77: 862-864. https://doi.org/10.1111/his.14226.
Mete O, Asa SL (2013) Precursor lesions of endocrine system neoplasms. Pathol 45: 316-330.
Chetty R, Kennedy M, Ezzat S, Asa SL (2004) Pancreatic endocrine pathology in von Hippel-Lindau disease: an expanding spectrum of lesions. Endocr Pathol 15: 141-148.
Yu R (2018) Mahvash Disease: 10 Years After Discovery. Pancreas 47: 511-515. https://doi.org/10.1097/MPA.0000000000001044
Iacovazzo D, Flanagan SE, Walker E, Quezado R, de Sousa Barros FA, Caswell R, Johnson MB, Wakeling M, Brandle M, Guo M, Dang MN, Gabrovska P, Niederle B, Christ E, Jenni S, Sipos B, Nieser M, Frilling A, Dhatariya K, Chanson P, de Herder WW, Konukiewitz B, Kloppel G, Stein R, Korbonits M, Ellard S (2018) MAFA missense mutation causes familial insulinomatosis and diabetes mellitus. Proc Natl Acad Sci U S A 115:1027–1032. 1712262115. https://doi.org/10.1073/pnas.1712262115
Asa, S. L. and Perry, A. (2020) Tumors of the Pituitary Gland. AFIP Atlas of Tumor and Non-Tumor Pathology, Series 5, Fascicle 1, Arlington VA: ARP Press. ISSN 0160–6344
Crooke AC (1935) A change in the basophil cells of the pituitary gland common to conditions which exhibit the syndrome attributed to basophil adenoma. J Pathol Bacteriol 41: 339-349.
Asa SL, Mete O (2021) Cytokeratin profiles in pituitary neuroendocrine tumors. Hum Pathol 107: 87–95. S0046–8177(20)30202–1. https://doi.org/10.1016/j.humpath.2020.10.004
Booth GL, Redelmeier DA, Grosman H, Kovacs K, Smyth HS, Ezzat S (1998) Improved diagnostic accuracy of inferior petrosal sinus sampling over imaging for localizing pituitary pathology in patients with Cushing’s disease. J Clin Endocrinol Metab 83: 2291-2295.
Yang H-J, Ozawa H, Kurosumi K (1989) Ultrastructural changes in growth hormone cells in the rat anterior pituitary after thyroidectomy as studied by immunoelectron microscopy and enzyme histochemistry. J Clin Electr Microsco 22: 269-283.
Kovacs K, Horvath E, Rewcastle NB, Ezrin C (1980) Gonadotroph cell adenoma of the pituitary in a woman with long-standing hypogonadism. Arch Gynecol 229: 57-65.
Article CAS PubMed Google Scholar
Scheithauer BW, Kovacs K, Young WF, Jr., Randall RV (1992) The pituitary in hyperthyroidism. Mayo Clin Proc 67: 22-26.
Article CAS PubMed Google Scholar
Duan K, Asa SL, Winer D, Gelareh Z, Gentili F, Mete O (2017) Xanthomatous Hypophysitis Is Associated with Ruptured Rathke’s Cleft Cyst. Endocr Pathol 28: 83-90. https://doi.org/10.1007/s12022-017-9471-x.
Paulus W, Honegger J, Keyvani K, Fahlbusch R (1999) Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol 97: 377-382.
Article CAS PubMed Google Scholar
Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Solorzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE (2016) The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg 151:959–968. https://doi.org/10.1001/jamasurg.2016.2310
Asa SL (2020) Survival Guide to Endocrine Pathology. Virginia: Innovative Pathology Press. ISBN 1734491604
Asa SL, Mete O (2018) Parathyroids. In: Mills SE, editors. Histology for Pathologists. Philadelphia: Wolters Kluwer. pp. 1201-1224. ISBN 1496398947
Nose V, Gill A, Teijeiro JMC, Perren A, Erickson L (2022) Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes. Endocr Pathol 33: 197-227. https://doi.org/10.1007/s12022-022-09705-5.
Carney JA, Sizemore GW, Sheps SG (1976) Adrenal medullary disease in multiple endocrine neoplasia, type 2: pheochromocytoma and its precursors. Am J Clin Pathol 66: 279-290.
Article CAS PubMed Google Scholar
DeLellis RA, Wolfe HJ, Gagel RF, Feldman ZT, Miller HH, Gang DL, Reichlin S (1976) Adrenal medullary hyperplasia. A morphometric analysis in patients with familial medullary thyroid carcinoma. Am J Pathol 83: 177-196.
CAS PubMed PubMed Central Google Scholar
Grogan RH, Pacak K, Pasche L, Huynh TT, Greco RS (2011) Bilateral adrenal medullary hyperplasia associated with an SDHB mutation. J Clin Oncol 29: e200-e202. JCO.2010.32.2156. https://doi.org/10.1200/JCO.2010.32.2156
Toledo SP, Lourenco DM, Jr., Sekiya T, Lucon AM, Baena ME, Castro CC, Bortolotto LA, Zerbini MC, Siqueira SA, Toledo RA, Dahia PL (2015) Penetrance and clinical features of pheochromocytoma in a six-generation family carrying a germline TMEM127 mutation. J Clin Endocrinol Metab 100: E308–E318. https://doi.org/10.1210/jc.2014-2473.
Hernandez KG, Ezzat S, Morel CF, Swallow C, Otremba M, Dickson BC, Asa SL, Mete O (2015) Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the association. Virchows Arch 466: 727-732. https://doi.org/10.1007/s00428-015-1755-2.
Romanet P, Guerin C, Pedini P, Essamet W, Castinetti F, Sebag F, Roche P, Cascon A, Tischler AS, Pacak K, Barlier A, Taieb D (2017) Pathological and Genetic Characterization of Bilateral Adrenomedullary Hyperplasia in a Patient with Germline MAX Mutation. Endocr Pathol 28: 302-307. https://doi.org/10.1007/s12022-016-9460-5.
Tischler AS, Semple J (1996) Adrenal Medullary Nodules in Beckwith-Wiedemann Syndrome Resemble Extra-Adrenal Paraganglia. Endocr Pathol 7:265–272. EP0704265
Korpershoek E, Petri BJ, Post E, van Eijck CH, Oldenburg RA, Belt EJ, de Herder WW, de Krijger RR, Dinjens WN (2014) Adrenal medullary hyperplasia is a precursor lesion for pheochromocytoma in MEN2 syndrome. Neoplasia 16: 868-873. https://doi.org/10.1016/j.neo.2014.09.002
Schroeder JO, Asa SL, Kovacs K, Killinger D, Hadley GL, Volpé R (1984) Report of a case of pheochromocytoma producing immunoreactive ACTH and beta-endorphin. J Endocrinol Invest 7: 117-121.
Article CAS PubMed Google Scholar
Mete O, Asa SL (2012) Morphological distinction of cortisol-producing and aldosterone-producing adrenal cortical adenomas: not only possible but a critical clinical responsibility. Histopathology.
Williams TA, Gomez-Sanchez CE, Rainey WE, Giordano TJ, Lam AK, Marker A, Mete O, Yamazaki Y, Zerbini MCN, Beuschlein F, Satoh F, Burrello J, Schneider H, Lenders JWM, Mulatero P, Castellano I, Knosel T, Papotti M, Saeger W, Sasano H, Reincke M (2021) International Histopathology Consensus for Unilateral Primary Aldosteronism. J Clin Endocrinol Metab 106: 42–54. 5876946; dgaa484. https://doi.org/10.1210/clinem/dgaa484
Mete O, Asa SL, Giordano TJ, Papotti M, Sasano H, Volante M (2018) Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms. Endocr Pathol 29: 137-149. https://doi.org/10.1007/s12022-018-9525-8.
留言 (0)